Cortexyme Receives $350,000 New Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1609 Kirkham St. San Francisco, CA 94122 USA
  • Company Description
    Cortexyme is developing novel treatments for altering the course of Alzheimer’s and other neurological diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.